Dr. Lauren Sarah Singer, MD

Dr. Singer practices at The University of Chicago Medical Center in Chicago, Illinois.

Dr. Singer's NPI, 1720518723, was assigned on June 13, 2017. Dr. Singer holds Illinois license 036152632.

Dr. Singer's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Singer's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Dr. Singer is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Singer to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices. Vendor and product names are available with a free account.

Neurology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Singer is licensed in Illinois.

CMS data shows 347 Medicare services from Dr. Singer across 4 procedure codes in 2024, for 132 Medicare patients. Medicare paid $25,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 132 Medicare patients who saw Dr. Singer in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 68, with 64% women.

In 2024, Dr. Singer wrote 117 Medicare Part D claims for 36 patients. 81% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $1,569 in total drug cost. In 2019, CMS named 18 claims across 1 drug.

Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singer as offering telehealth.

Dmand AI links 10 papers to Dr. Singer, published from 2021 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Central Nervous System Neoplasms and Glioma. Dr. Singer has published most often in Chin Clin Oncol. Dr. Singer's most frequent co-authors are Priya Uday Kumthekar, MD, Rimas Vincas Lukas, MD and Karan S. Dixit, MD.

CMS Open Payments shows 10 general payments to Dr. Singer from 7 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Aveo Pharmaceuticals, Inc. paid the most, $238.